Pharmaceutical Outsourcing - Executive Summary Q3 2018

Published on: 09/10/2018

Contract Research Organizations (CROs) remain the most targeted segment in the Pharmaceutical Outsourcing industry, accounting for 45.2% of deals to-date in 2018 compared to 38.3% in all of 2017. Buyers have sought to cut clinical trial times and reduce spending through these strategic acquisitions.  In August, Capstone Headwaters advised Gibraltar Laboratories on its sale to Sotera Health LLC, a portfolio company of Warburg Pincus and GTCR. 

Key Contacts